Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

By Holmes A.   Heilig M.   Rupniak N.M.J.   Steckler T.   Griebel G.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 11, 2003-11 ,pp. : 580-588

Elsevier

Access to resources Recommend Favorite

Selective Targeting of Muscarinic Receptors: Novel Therapeutic Approaches for Psychotic Disorders

By  

Current Neuropharmacology, Vol. 3, Iss. 1, 2005-01 ,pp. : 63-71

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutic Approaches Targeting Matrix Metalloproteinases in Cardiovascular Disease

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 10, 2012-05 ,pp. : 1214-1221

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches for Developing Novel Microtubule Targeting Agents (MTAs) for Therapeutic Exploitation

By  

Current Pharmaceutical Design, Vol. 18, Iss. 19, 2012-06 ,pp. : 2804-2810

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches Targeting KV10.1 Open a Novel Window for Cancer Diagnosis and Therapy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 5, 2012-02 ,pp. : 675-682

Bentham Science Publishers

Access to resources Recommend Favorite